Key Highlights
- Michele Holcomb, PhD, joins PureTech Health board as an independent non-executive director, effective September 23, 2024.
- Dr. Holcomb brings over 30 years of strategic leadership in global healthcare.
- She will contribute to PureTech’s growth strategy with her expertise in biopharma and healthcare innovation.
Source: Business Wire
Notable Quotes
- “She has a proven track record of leading transformational growth initiatives and driving organizational progress that will complement our board’s exceptional leadership.” — Bharatt Chowrira, PhD, JD, Chief Executive Officer at PureTech
- “I am excited and honored to work with my fellow board members and the PureTech management team to guide the Company through the next stage of evolution.” — Michele Holcomb, PhD – Independent Non-Executive Director at PureTech Health
- “Her unique insights and strategic vision will be instrumental as we work to advance our company’s mission.” — Raju Kucherlapati, PhD, Chair of the Board of Directors at PureTech Health
SoHC's Take
The appointment of Dr. Michele Holcomb to PureTech Health’s board is a strategic move that underscores the company’s commitment to growth and innovation. Dr. Holcomb’s extensive background in biopharma, coupled with her leadership roles at major healthcare organizations like Cardinal Health and Teva Pharmaceuticals, positions her as a valuable asset to PureTech. Her experience in driving transformational growth and her deep understanding of the healthcare landscape will be pivotal as PureTech continues to advance its innovative therapeutic programs. This appointment signals PureTech’s forward momentum in achieving its mission of delivering groundbreaking medicines to patients worldwide.
